Clinical investigation of bacteremia in children with hemato-oncologic diseases

Infection and Chemotherapy

Volumn 43, Issue 2, 2011, Pages 191-195

  Ko, Eun Young ^a   Kang, Hyun Ju ^a   Kwon, Hyo Jin ^a   Choi, Ui Yoon ^a   Lee, Jae Wook ^a   Lee, Dong Gun ^a   Park, Yeon Joon ^a   Chung, Nak Gyun ^a   Cho, Bin ^a   Kim, Hack Ki ^a   Kang, Jin Han ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antimicrobial susceptibility; Bacteremia; Child; Neutropenia

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECIUM; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; NEUTROPENIA; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS;

EID: 80054056945     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2011.43.2.191     Document Type: Article

References (29)

1. Kaddan-Lottick NS. Epidemiology of childhood and adolescent cancer. In: Kliegman RM, Behman RE, Jenson HB, Stanton BF, eds. Nelson textbook of pediatrics. 18th ed. Philadelphia: WB Saunders Co.; 2007;2097-9.
2. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005;40 (Suppl 4):S240-5.
3. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
4. Lee HJ, Lee JW, Kim JH, Lee KH, Chung NG, Lee DG, Lee MJ, Choi SH, Kang JH, Lee SJ, Jeong DC, Cho B, Kim HK. A survey for causative organisms and antimicrobial susceptibilities of bacteremia in a single center children with hemato-oncologic diseases (2004~2006). Clin Pediatr Hematol Oncol 2008;15:65-74.
5. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
6. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-72.
7. Schimpff SC. Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 1986;80:13-20.
8. Yun BY, Lee LH. Septicemia in children with neoplastic disease. J Korean Pediatr Soc 1992;35:1481-92.
9. Marron A, Carratalà J, Alcaide F, Fernández-Sevilla A, Gudiol F. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. J Antimicrob Chemother 2001;47:87-91.
10. Lee DG, Choi SM, Choi JH, Yoo JH, Park YH, Kim YJ, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial. Korean J Intern Med 2002;17:38-44.
11. Choi EH, Pyo JW, Park JY, Kwon KB, Yun BY, Shin HY, Lee HJ, Ahn HS. Infections in children with neoplastic disease. J Korean Pediatr Soc 1995;38:366-77.
12. Kim YH, Lee HD, Hah JO. Bacteremia in pediatric cancer patients: causative organisms and antibiotic sensitivities. Korean J Pediatr 2005;48:619-23.
13. Park HW, Youn HS, Im HJ, Kim MN, Seo JJ, Moon HN. Risk factors of bloodstream infection associated mortality in pediatric patients with hemato-oncologic disease. Korean J Hematol 2007;42: 343-52.
14. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
15. Celkan T, Ozkan A, Apak H, Diren S, Can G, Yuksel L, Yildiz I. Bacteremia in childhood cancer. J Trop Pediatr 2002;48:373-7.
16. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 2000;14:129-35.
17. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002;34:1524-9.
18. Weisman SJ, Scoopo FJ, Johnson GM, Altman AJ. Quinn JJ. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol 1990;8:453-9.
19. Uh Y, Hwang GY, Jang IH, Yoon KJ, Kim HY. Antimicrobial susceptibilities of viridans streptococci isolated recently. J Lab Med Qual Assur 2002;24:225-30.
20. Cho EH, Lee NY. Clinical significance of viridans streptococcal bacteremia. Korean J Lab Med 2003;23:246-50.
21. Kim SH, Lee YA, Eun BW, Kim NH, Lee JA, Kang HJ, Choi EH, Shin HY, Lee HJ, Ahn HS. Etiological agents isolated from blood in children with hemato-oncologic diseases (2002-2005). Korean J Pediatr 2007;50:56-64.
22. Park SM, Choe BK, Kim CS, Kim JS, Kim HS, Ryoo NH. Bacteremia in pediatric cancer patients: a single center study. Korean J Pediatr 2006;49:882-8.
23. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-12.
24. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16:102-11.
25. Caselli D, Cesaro S, Ziino O, Zanazzo G, Manicone R, Livadiotti S, Cellini M, Frenos S, Milano GM, Cappelli B, Licciardello M, Beretta C, Aricò M, Castagnola E; Infection Study Group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica 2010;95:1612-5.
26. Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simões BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007;39:775-81.
27. Song JH. Current status and future strategies of antimicrobial resistance in Korea. Korean J Med 2009;77:143-51.
28. Brown AE. Management in the febrile, neutropenic patient with cancer: therapeutic considerations. J Pediatr 1985;106:1035-42.
29. Yoo JH, Choi SM, Lee DG, Choi JH, Shin WS, Min WS, Kim CC. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea. J Korean Med Sci 2005;20:31-5.